BCL2 and AL amyloidosis: Although our results demonstrated that BCL-2 inhibitors effectively induce apoptosis in AL amyloidosis clonal plasma cells, we next investigated whether this would continue to be evident in vivo and how this therapy would compare with the standard of care, bortezomib.